Y90
Showing 1 - 25 of >10,000
Cancer Trial in Manchester (Y90-PET-CT scan)
Recruiting
- Cancer
- Y90-PET-CT scan
-
Manchester, United KingdomThe Christie NHS - Nuclear Medicine Department
Nov 7, 2023
Locally Advanced Hepatocellular Carcinoma Trial in Singapore (SIRT-Y90 with Atezolizumab + Bevacizumab, SIRT-Y90 with Placebo
Recruiting
- Locally Advanced Hepatocellular Carcinoma
- SIRT-Y90 with Atezolizumab + Bevacizumab
- SIRT-Y90 with Placebo (IV)
-
Singapore, Singapore
- +1 more
Jan 26, 2023
Liver Cancer Trial in Houston (device, diagnostic test, procedure)
Not yet recruiting
- Liver Cancer
- TriSalus™ TriNav™Infusion System
- +2 more
-
Houston, TexasMD Anderson Cancer Center
Feb 23, 2023
Hepatocellular Carcinoma Trial in United States (Y-90 TARE, Atezolizumab, Bevacizumab)
Recruiting
- Hepatocellular Carcinoma
- Y-90 TARE
- +2 more
-
Washington, District of Columbia
- +5 more
Jan 18, 2023
Colorectal Tumors Trial in Hangzhou (Resin microspheres containing yttrium-90 (Y-90))
Not yet recruiting
- Colorectal Neoplasms
- Resin microspheres containing yttrium-90 (Y-90)
-
Hangzhou, Zhejiang, ChinaSir Run Run Shaw Hospital (SRRSH), affiliated with the Zhejiang
Oct 11, 2023
Pancreatic Neuroendocrine Tumor Trial in Milano (peptide receptor radionuclide therapy with Y-90-DOTATOC)
Recruiting
- Pancreatic Neuroendocrine Tumor
- peptide receptor radionuclide therapy with Y-90-DOTATOC
-
Milano, Italy
- +1 more
Sep 30, 2022
HepatoCellular Carcinoma Trial in Singapore (Y-90 Radioembolization, Nivolumab)
Active, not recruiting
- HepatoCellular Carcinoma
- Y-90 Radioembolization
- Nivolumab
-
Singapore, SingaporeNational Cancer Centre - Singapore
May 25, 2022
Colorectal Cancer Metastatic, Colon Cancer, Metastatic Colorectal Cancer Trial in Iowa City (Durvalumab, Yttrium-90
Recruiting
- Colorectal Cancer Metastatic
- +9 more
- Durvalumab
- Yttrium-90 RadioEmbolization
-
Iowa City, IowaUniversity of Iowa Hospitals and Clinics
Mar 24, 2022
Bile Duct Cancer, Cholangiocarcinoma, Cholangiocarcinoma Non-resectable Trial in Boston (Gemcitabine, Cisplatin, Durvalumab)
Not yet recruiting
- Bile Duct Cancer
- +4 more
- Gemcitabine
- +3 more
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Jan 23, 2023
HCC, Cancer of Liver, Cancer Trial in Atlanta (SIR-Spheres microspheres)
Completed
- HCC
- +2 more
- SIR-Spheres microspheres
-
Atlanta, Georgia
- +2 more
Dec 22, 2021
BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma, Locally Advanced Hepatocellular Carcinoma Trial in
Withdrawn
- BCLC Stage B Hepatocellular Carcinoma
- +4 more
- Atezolizumab
- +3 more
- (no location specified)
Dec 12, 2022
Colon Cancer, Rectal Cancer, Liver Metastases Trial in San Francisco (Tas-102, SIR-Sphere)
Completed
- Colon Cancer
- +2 more
- Tas-102
- SIR-Sphere
-
San Francisco, CaliforniaUniversity of California San Francisco
Jul 28, 2022
Hepatocellular Carcinoma Trial in Guangzhou (SIRT)
Not yet recruiting
- Hepatocellular Carcinoma
- SIRT
-
Guangzhou, Guangdong, ChinaThe Second Affiliated Hospital of Guangzhou Medical University
Aug 9, 2023
Utilizing Flex-dosing for Unresectable HCC With Y90 SIR-Spheres
Recruiting
- Hepatocellular Carcinoma
- SIRT with Y-90 resin microspheres
-
Dallas, TexasMethodist Dallas Medical Center
Nov 9, 2021
Hepatocellular Carcinoma (HCC), Unresectable Hepatocellular Carcinoma Trial in Ann Arbor (drug, device, radiation, diagnostic
Recruiting
- Hepatocellular Carcinoma (HCC)
- Unresectable Hepatocellular Carcinoma
- Yttrium-90
- +4 more
-
Ann Arbor, MichiganUniversity of Michigan Rogel Cancer Center
Dec 16, 2021
Optimizing Y90 Therapy for Radiation Lobectomy
Recruiting
- HCC
- +4 more
- Y90 radioembolization
-
Chicago, IllinoisNorthwestern University
Aug 27, 2021
Liver Cancer, Hepatoma Trial (Yttrium 90 (TheraSphere))
Completed
- Liver Cancer
- Hepatoma
- Yttrium 90 (TheraSphere)
- (no location specified)
Sep 28, 2022
Primary Malignant Liver Tumor Trial in Palo Alto (procedure, device, diagnostic test)
Completed
- Primary Malignant Liver Neoplasm
- Computed Tomography (CT)
- +4 more
-
Palo Alto, CaliforniaStanford University
Dec 8, 2021
Hepatocellular Carcinoma Trial in Guangzhou (Lenvatinib, sintilimab plus SIRT)
Not yet recruiting
- Hepatocellular Carcinoma
- Lenvatinib, sintilimab plus SIRT
-
Guangzhou, Guangdong, ChinaThe Second Affiliated Hospital of Guangzhou Medical University
Aug 8, 2023
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Duarte (procedure, biological, drug,
Recruiting
- Acute Lymphoblastic Leukemia
- +3 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +8 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jan 12, 2023
Stage III Hepatocellular Carcinoma AJCC v8, Stage IIIA Hepatocellular Carcinoma AJCC v8, Stage IIIB Hepatocellular Carcinoma
Completed
- Stage III Hepatocellular Carcinoma AJCC v8
- +6 more
- Yttrium Y 90 Glass Microspheres
-
Houston, TexasM D Anderson Cancer Center
Oct 12, 2022
Hepatocellular Carcinoma Trial in Chicago (Atezolizumab and Bevacizumab, Y90 + TKI)
Not yet recruiting
- Hepatocellular Carcinoma
- Atezolizumab and Bevacizumab
- Y90 + TKI
-
Chicago, IllinoisNorthwestern University
Nov 11, 2022
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Carcinoma in the Liver Trial in Atlanta
Not yet recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +3 more
- Y-90 SIR-Spheres
- +2 more
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Jun 7, 2022
GVHD, Leukemia, Lymphoma Trial in Duarte (biological, drug, procedure, radiation, other)
Active, not recruiting
- Graft Versus Host Disease
- +2 more
- rituximab
- +8 more
-
Duarte, CaliforniaCity of Hope Medical Center
Mar 17, 2022